Growing body of clinical evidence supports use of Company’s FDA-Cleared BNA™ platform to provide objective measures of drug efficacy and cognitive change, driving innovation in brain health...
KENMORE, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions...
TORONTO, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1099 | -3.01095890411 | 3.65 | 3.8499 | 3.18 | 145578 | 3.50028475 | CS |
4 | 0.8801 | 33.0864661654 | 2.66 | 5.8 | 1.86 | 8559286 | 3.14997197 | CS |
12 | 0.2701 | 8.25993883792 | 3.27 | 5.8 | 1.86 | 2732795 | 3.14701022 | CS |
26 | -3.9599 | -52.7986666667 | 7.5 | 9 | 1.86 | 1364171 | 3.22690722 | CS |
52 | -3.9599 | -52.7986666667 | 7.5 | 9 | 1.86 | 1364171 | 3.22690722 | CS |
156 | -3.9599 | -52.7986666667 | 7.5 | 9 | 1.86 | 1364171 | 3.22690722 | CS |
260 | -3.9599 | -52.7986666667 | 7.5 | 9 | 1.86 | 1364171 | 3.22690722 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales